Competitor Analysis- Cancer Vaccines


Published on

Market Research Reports, Inc. has announced the addition of “Competitor Analysis- Cancer Vaccines” research report to their offering. See more visit -

Published in: Business
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Competitor Analysis- Cancer Vaccines

  1. 1. Category : Pharma & Healthcare All logos and Images mentioned on this slide belong to their respective owners.
  2. 2. Introduction to Report  Launch Date: March 25, 2014  Number of Pages: 179  Geography Coverage: Global  Available Format: PDF Price For Single User License: USD 1,112 Price For Site License: USD 2,224 Price For Global User License: USD 3,336 Delivery Time: Within 24 Hours (During Working Days)
  3. 3. About the Report The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines to fight cancer as of March 2014. The report includes a compilation of currently active projects in research and development for prophylaxis and therapy of cancer. In addition, the report lists company-specific R&D pipelines of cancer vaccines. Competitor projects are listed in a tabular format providing information on: Drug Codes Target / Mechanism of Action Class of Compound Company Product Category Indication R&D Stage and
  4. 4. Research Findings Projects are listed according to their main antigenic constituents: peptides, recombinant proteins, idiotype antibody, DNA (plasmid, expression vector), RNA, virus- like particles (VLP), dendritic cells, tumor cells (tumor cell lines), microorganism-based and others. Of the 140 clinical stage cancer vaccines, three were approved and are commercialized in the major pharmaceutical markets with combined 2013 sales of US$ 2,385 mln. Peptides and proteins make out 43% of clinical stage cancer vaccines, followed by dendritic cell and tumor cell (line)-based cancer vaccines with each contributing 15% to the clinical cancer vaccine pipeline. DNA- and RNA- based cancer vaccines maked out 17% of the clinical portfolio.
  5. 5. About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
  6. 6. Report Coverage 1. Cancer Vaccines by Main Composition  Peptide-based Cancer Vaccines  Protein-based Cancer Vaccines  Idiotype Antibody-based Cancer Vaccines  DNA-based Cancer Vaccines: naked and virally vectored  RNA-based Cancer Vaccines  Virus-Like Particle (VLP)-based Cancer Vaccines  Dendritic Cell-based Cancer Vaccines  Tumor Cell and Tumor Cell Line – based Cancer Vaccines  Microorganism-based Cancer Vaccines  Other and Not Defined Cancer Vaccines 2. Corporate Cancer Vaccines R&D Pipelines For more details regarding Report coverage see the last slide All logos and Images mentioned on this slide belong to their respective owners.
  7. 7. Company Coverage (Partial List) 1. ABIVAX 2. Activartis 3. Aduro BioTech 4. Advanced Cancer Therapeutics 5. Advaxis 6. Aeterna Zentaris 7. Agenus 8. Antigen Express 9. ApoVax 10.Ascend Biopharmaceuticals 11.Asterias Biotherapeutics 12.Avax Technologies 13.Bavarian Nordic 14.Bellicum Pharmaceuticals 15.Bharat Biotech For more details regarding Report coverage see the last slide All logos and Images mentioned on this slide belong to their respective owners.
  8. 8. Custom Research:  Are you an industry professional, entrepreneur, venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research. For Any Customization Related query Visit IdeaCenter @
  9. 9. How To Buy This Report? Visit following URL to see Table of Content and purchase this publication: About Market Research Reports, Inc. Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”. Contact : Amitava Sen Email : Phone: +1 302-703-7787 (USA) +91-8762746600 (India)